Recently, a number of studies have investigated the association between DNMT3A variants and cancer risk [8–15], and proposed a putative functional variant (rs1550117) in the 448bp upstream of the transcription start site of DNMT3A gene promoter [10]. The gene discussed is DNMT3A; the disease is cancer.